A Quantum Leap in Diagnostics
Discover Voxel System's Patented VxMRS™
VISION
Advancing the World of Diagnostics
Voxel is revolutionizing Magnetic Resonance Imaging (MRI) to transform early disease detection. Our vision is to empower MRI machines globally to go beyond imaging, to become the gold standard in early diagnostics.
Our objective is to reveal the silent biochemical fingerprints of diseases before they take hold, offering hope and a chance for effective intervention to millions.
By identifying illness earlier, we aim to extend quality of life and be part of a new era of personalized, predictive medicine.
OUR PRODUCT
Biochemical Fingerprint
VxMRS™
Full Spectrum
of Biochemicals
3 Min
Scan
With over 15 years of research and development, the US Government developed and patented an adaptive Magnetic Resonance Spectroscopy (MRS) algorithm that yields a full spectrum of biochemical fingerprints in human tissue utilizing a conventional MRI scanner. Voxel was awarded the exclusive license to this patented technology.
The proprietary AI techniques has charted a new path for early diagnostics giving physicians and patients valuable evidence for assessing health so that earlier or better interventions can be planned.
Cloud-Based
Acquisition
of MR Scans
The brain continues to be the final frontier for diagnostics in current medical practice. Tissue biopsies and lumbar punctures are invasive and associated with significant risks, while blood biomarkers have not yet reached mainstream diagnostics due to a number of limitations including the blood brain barrier.
Voxel’s AI driven and cloud-based VxMRS™, utilizes existing MRI machines and "transforms" them from water molecule scanners into advanced biochemical scanners capable of detecting disease-specific chemical fingerprints for multiple diseases.
VxMRS™ data creates a new paradigm of diagnostics and replaces visual interpretation with biochemical spectra.
The VxMRS™ algorithm has demonstrated its efficacy in identifying conditions including Alzheimer’s Disease, Mild Cognitive Impairment, Dementia, Traumatic Brain Injury, Psychological disorders and brain cancer.
VxMRS™ seeks to track disease progression over time, and potentially monitor the efficacy of clinical treatment and drug therapies.
Brain
Exploration
